These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23963542)

  • 1. Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia.
    Mansoor SM; Aslani P; Krass I
    Int J Clin Pharm; 2014 Feb; 36(1):136-44. PubMed ID: 23963542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach.
    Mansoor SM; Krass I; Costa DS; Aslani P
    Res Social Adm Pharm; 2015; 11(6):769-83. PubMed ID: 25749550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing community pharmacists' provision of medication adherence support to older adults: A mixed methods study using the Theoretical Domains Framework.
    Patton DE; Ryan C; Hughes CM
    Res Social Adm Pharm; 2021 Feb; 17(2):406-418. PubMed ID: 32217058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' perceptions of services that benefit older people in New Zealand.
    Tordoff J; Chang SY; Norris PT
    Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?
    Aburuz S; Al-Ghazawi M; Snyder A
    Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance-based adherence support service delivery: consumer perspectives.
    Du Pasquier S; Aslani P
    Pharm World Sci; 2008 Dec; 30(6):846-53. PubMed ID: 18592393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease.
    Puspitasari HP; Costa DSJ; Aslani P; Krass I
    Res Social Adm Pharm; 2016; 12(1):104-118. PubMed ID: 26001624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qatar pharmacists' understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care.
    El Hajj MS; Al-Saeed HS; Khaja M
    Int J Clin Pharm; 2016 Apr; 38(2):330-43. PubMed ID: 26758716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence beliefs of U.S community pharmacists.
    Witry MJ
    Res Social Adm Pharm; 2018 May; 14(5):471-478. PubMed ID: 28655492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.
    Ghimire S; Banks C; Jose MD; Castelino RL; Zaidi STR
    Int J Clin Pharm; 2018 Feb; 40(1):26-35. PubMed ID: 29214368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers.
    Shami R; Alam MF; ElHajj MS
    Int J Clin Pharm; 2022 Feb; 44(1):214-226. PubMed ID: 34661831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London.
    Hesso I; Kayyali R; Nabhani-Gebara S
    BMC Health Serv Res; 2019 Jan; 19(1):5. PubMed ID: 30611264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication needs of patients with altered hearing ability: Informing pharmacists' patient care services through focus groups.
    Ferguson M; Liu M
    J Am Pharm Assoc (2003); 2015; 55(2):153-60. PubMed ID: 25700133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.